ArticleBMC cancer2020

Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study.

Jing-Jing Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.